Autor: "Lygirou, V" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Urine peptidome analysis in cardiorenal syndrome reflects molecular processes.
Autorzy:: Petra E; Institute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany.; Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
He T; Institute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany.; Mosaiques Diagnostics GmbH, Hannover, Germany.
Lygirou V; Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Latosinska A; Mosaiques Diagnostics GmbH, Hannover, Germany.
Mischak H; Mosaiques Diagnostics GmbH, Hannover, Germany.
Vlahou A; Biotechnology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Jankowski J; Institute for Molecular Cardiovascular Research, RWTH Aachen University Hospital, Pauwelsstraße 30, 52074, Aachen, Germany. .; Experimental Vascular Pathology, Cardiovascular Research Institute Maastricht (CARIM), University of Maastricht, Maastricht, The Netherlands. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Aug 10; Vol. 11 (1), pp. 16219. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cardio-Renal Syndrome/*pathology
Cardio-Renal Syndrome/*urine
Endopeptidases/*metabolism
Peptide Fragments/*urine
Urinalysis/*methods
Aged ; Case-Control Studies ; Female ; Humans ; Male ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Multiplexed MRM-based protein quantification of putative prognostic biomarkers for chronic kidney disease progression in plasma.
Autorzy:: Makridakis M; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Kontostathi G; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Petra E; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Stroggilos R; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Lygirou V; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Filip S; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Duranton F; RD-Néphrologie, Montpellier, France.
Mischak H; Mosaiques Diagnostics, Hannover, Germany.
Argiles A; RD-Néphrologie, Montpellier, France.
Zoidakis J; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece.
Vlahou A; Biotechnology Division, Biomedical Research Foundation, Academy of Athens (BRFAA), Athens, Greece. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Mar 16; Vol. 10 (1), pp. 4815. Date of Electronic Publication: 2020 Mar 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alpha-Globulins*
Complement C1 Inhibitor Protein*
Mass Spectrometry/*methods
Muramidase/*blood
Renal Insufficiency, Chronic/*diagnosis
beta 2-Microglobulin/*blood
Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Cohort Studies ; Disease Progression ; Female ; Follow-Up Studies ; Glomerular Filtration Rate ; Hemoglobin Subunits ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Lygirou, V"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język